A dozen or so European drug development startups might soon get a major lift from Jeito Capital. The Paris-based firm closed its second fund at

Eli Lilly may not have discovered orexins, but the pharma’s latest acquisition marks increasing momentum for a drug class that’s maturing after years of fine-tuning.

Health tech kicked off the year with a series of eye-popping funding rounds. Whoop raised a $575 million Series G last week. Others, like OpenEvidence,

Diabetes patients in Medicare spent significantly less on insulin in the first year after a $35 monthly cap was put in place in 2023 —

The White House this week began offering a $950-per-month version of AbbVie’s megablockbuster Humira on TrumpRx, even as the drug discount website also offers two